BRAF and differentiated thyroid carcinoma: The BRAF V600E mutation, a genetic alteration involving a valine-to-glutamate substitution at position 600 of the BRAF gene, is particularly noteworthy due to its strong association with papillary thyroid carcinoma (PTC) [5].